Neil F. Mcfarlane
CEO, President at Zevra Therapeutics, Inc. (ZVRA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 13SEC | ZVRAZevra Therapeutics, Inc. | Sell Plan | 20,000417,225 held (−5%) | $11.25 | $225K | -11.6% |
| Feb 10SEC | ZVRAZevra Therapeutics, Inc. | Sell Plan | 14,625387,225 held (−4%) | $8.56 | $125K | +16.1% |
| Feb 2SEC | ZVRAZevra Therapeutics, Inc. | Sell Plan | 91,000364,350 held (−20%) | $9.38 | $854K | +6.0% |
| Oct 10SEC | ZVRAZevra Therapeutics, Inc. | Sell Plan | 19,500222,016 held (−8%) | $10.82 | $211K | -8.1% |
- Sell
CEO, President Neil F. Mcfarlane sold $225K of ZVRA at $11.25 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Neil F. Mcfarlane sold $125K of ZVRA at $8.56 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Neil F. Mcfarlane sold $854K of ZVRA at $9.38 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Neil F. Mcfarlane sold $211K of ZVRA at $10.82 — pre-scheduled 10b5-1 plan sale.